About Daiichi Sankyo

The business integration of DAIICHI and SANKYO brings together two pharmaceutical companies bound by a century of vision and a legacy of firsts. To physicians, this means objective data, the highest ethical standards, and a desire to deliver practical human benefits with each product we develop. To our partners, we balance the strength and stability of our global presence with the spirit, agility, and quick reaction times of much smaller companies. To our employees, we offer an operational structure that balances creativity with discipline and individualism with collaboration. To patients, we are committed to developing medications that put lives into balance and add to the balance of life.

We believe good science walks hand-in-hand with humanity and, as we move forward into our next century, we seek to build on our history of discovery with the development of new therapies in cardiovascular disease, cancer, metabolic disorders and infection.

We employ 15,400 people worldwide.

Daiichi Sankyo UK

Our U.K ultra-modern office in leafy Buckinghamshire provides easy transport links and the space to run not only large meetings but most of our training too. We have 129 employees consisting of Primary & Secondary Care Business Units, Medical and Regulatory,Business Intelligence, Finance, I.T, People Services and Performance Development teams. By investing in technology, business intelligence and competitive employment benefits, we are able to attract the best people.

The DAIICHI SANKYO indication areas:

- Cardiovascular disease
- Diabetic and metabolic disorders
- Bone/joint disease
- Infectious disease
- Cancer
- Immunologiecal/allergic disease

For more information on roles within this company please contact your Daiichi Sankyo Account Manager